Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy-Reference-Cited by-同舟云学术

Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy

Published:2001-05 Issue:5 Volume:12 Page:685-691
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gazet J.-C.,Ford H.T.,Gray R.,McConkey C.,Sutcliffe R.,Quilliam J.,Makinde V.,Lowndes S.,Coombes R.C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/5/685/19479281/12-5-685.pdf

Reference24 articles.

1. Multimodal treatment for locally advanced breast cancer. Results of chemotherapy-radiotherapy versus chemotherapy-surgery;De Lena;Cancer Clin Trials,1981

2. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer;Swain;Cancer Res,1987

3. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A cancer and Leukemia Group B study;Perloff;J Clin Oncol,1988

4. Prospective randomised trial of Tamoxifen versus surgery in elderly patients with breast cancer;Gazet;Lancet,1988

5. Primary medical (neoadjuvant) chemotherapy for operable breast cancer;Smith;Eur J Cancer,1993

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival;Cancer Medicine;2024-02

2. Changing the role of pCR in breast cancer treatment - an unjustifiable interpretation of a good prognostic factor as a “factor for a good prognosis“;Frontiers in Oncology;2023-07-18

3. Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials;Breast Cancer: Targets and Therapy;2022-10

4. Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;American Journal of Therapeutics;2021-01

5. A Case of Breast Cancer with a Rapid Decrease in Tumor Size after Cessation of Hormone Replacement Therapy;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2021